# A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer

> **NCT06075810** · PHASE1 · RECRUITING · sponsor: **MBQ Pharma** · enrollment: 48 (estimated)

## Conditions studied

- Breast Cancer
- Breast Neoplasm
- Breast Cancer Stage IV

## Interventions

- **DRUG:** MBQ-167

## Key facts

- **NCT ID:** NCT06075810
- **Lead sponsor:** MBQ Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-09
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06075810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06075810, "A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06075810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*